MYCOPATHOLOGIA

Scope & Guideline

Fostering breakthroughs in veterinary microbiology.

Introduction

Welcome to your portal for understanding MYCOPATHOLOGIA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0301-486x
PublisherSPRINGER
Support Open AccessNo
CountryNetherlands
TypeJournal
Convergefrom 1938 to 1941, 1943, from 1949 to 1950, from 1959 to 1962, from 1974 to 2024
AbbreviationMYCOPATHOLOGIA / Mycopathologia
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressVAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS

Aims and Scopes

The journal 'MYCOPATHOLOGIA' focuses on the study of fungal diseases, their epidemiology, diagnosis, treatment, and the underlying mechanisms of pathogenicity. It serves as a platform for researchers and clinicians to share significant findings in the field of mycology, with an emphasis on both clinical and environmental aspects of fungal infections.
  1. Clinical Mycology:
    This area encompasses research related to the diagnosis, treatment, and management of fungal infections in humans, including emerging and drug-resistant pathogens.
  2. Molecular and Genomic Studies:
    Research focusing on the genetic and molecular characteristics of fungi, including their resistance mechanisms, which aids in understanding pathogenicity and developing targeted treatments.
  3. Epidemiology and Public Health:
    Studies that investigate the distribution, determinants, and control of fungal diseases, particularly in vulnerable populations and in relation to global health crises.
  4. Innovative Diagnostic Techniques:
    Development and evaluation of new diagnostic methods, such as metagenomics, next-generation sequencing, and immunological assays, to improve detection and management of fungal infections.
  5. Environmental Mycology:
    Exploration of fungal flora in various environments, their interactions with hosts, and their roles in health and disease, especially in relation to climate change and ecological impacts.
  6. Therapeutic Strategies:
    Research on antifungal treatments, including novel agents and combination therapies, aimed at overcoming resistance and improving patient outcomes.
The journal 'MYCOPATHOLOGIA' has seen an evolution in its themes, reflecting current challenges in fungal research and clinical practice. Emerging trends indicate a shift towards more integrated and innovative approaches in the study of mycoses.
  1. COVID-19-Associated Fungal Infections:
    Research on fungal infections linked to COVID-19, such as mucormycosis and aspergillosis, has surged, highlighting the impact of the pandemic on fungal disease epidemiology and management.
  2. Antifungal Resistance Mechanisms:
    A growing body of work is focused on understanding the mechanisms of antifungal resistance in various pathogens, contributing to the development of new treatment strategies.
  3. Metagenomic and Next-Generation Sequencing Applications:
    The application of advanced sequencing technologies for the diagnosis of fungal infections is becoming increasingly prominent, allowing for more precise and comprehensive pathogen identification.
  4. Fungal Co-infections in Immunocompromised Patients:
    There is an increasing emphasis on studying fungal co-infections in patients with underlying conditions, such as HIV/AIDS and cancer, especially in relation to treatment outcomes.
  5. Environmental and Climate Impact on Fungal Diseases:
    Research is emerging around the influence of environmental changes and climate on fungal disease patterns, which is critical for public health planning and response.
  6. Pediatric Fungal Infections:
    The focus on fungal infections in pediatric populations is increasing, addressing unique challenges in diagnosis and treatment in this vulnerable group.

Declining or Waning

While 'MYCOPATHOLOGIA' continues to cover a broad range of topics in mycology, certain areas of research have seen a decline in focus. This may reflect changing priorities in the field or a shift towards more pressing issues related to fungal infections.
  1. Traditional Mycological Techniques:
    There has been a noticeable decline in studies focusing solely on classical culture methods for fungal identification, as molecular techniques become more prevalent and preferred.
  2. Non-invasive Diagnostic Approaches:
    Research on older non-invasive diagnostic methods is diminishing, likely due to the growing emphasis on more accurate and rapid molecular diagnostics.
  3. Fungal Diseases in Non-Human Hosts:
    While still relevant, there appears to be a waning interest in researching fungal infections primarily affecting non-human hosts, potentially overshadowed by the human health focus.
  4. Historical Perspectives on Fungal Infections:
    Papers that provide retrospective analyses or historical data seem to be decreasing, possibly as the field moves towards contemporary issues and emerging pathogens.
  5. Basic Research on Fungal Biology:
    There is a reduced emphasis on fundamental studies of fungal biology and ecology that do not directly relate to human health impacts or clinical applications.

Similar Journals

CURRENT OPINION IN INFECTIOUS DISEASES

Transforming Knowledge into Practice in Infectious Diseases
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0951-7375Frequency: 6 issues/year

CURRENT OPINION IN INFECTIOUS DISEASES, published by Lippincott Williams & Wilkins, is a premier journal that focuses on the latest developments and understanding in the field of infectious diseases. With its ISSN 0951-7375 and E-ISSN 1473-6527, this journal has gained recognition for its pivotal role in advancing knowledge from 1988 to its current publications in 2024. Boasting an impressive Q1 ranking in both Infectious Diseases and the Medical Microbiology category, it holds a reputable position among the top journals in the field. The journal serves as an essential resource for researchers, professionals, and students alike, providing them with timely reviews, analyses, and perspectives that shape contemporary practice and policy. While lacking open access options, it ensures a critical examination of emerging trends and unique insights that foster informed discussions. With its consistently high impact factor, CURRENT OPINION IN INFECTIOUS DISEASES remains a vital platform for thought leaders and innovators navigating the complexities of infectious disease research.

MEDICAL MYCOLOGY

Advancing the Frontiers of Fungal Research
Publisher: OXFORD UNIV PRESSISSN: 1369-3786Frequency: 8 issues/year

MEDICAL MYCOLOGY, published by Oxford University Press, is a premier journal dedicated to the study of fungal infections and their clinical implications. With an ISSN of 1369-3786 and an E-ISSN of 1460-2709, this journal has established itself as a vital resource in the fields of Infectious Diseases and Medicine, holding a respectable Q2 ranking for both categories and a Q1 ranking in the veterinary sector in 2023. Spanning a rich history from 1962 to 2024, MEDICAL MYCOLOGY serves as a platform for innovative research, case reports, and review articles that contribute to the understanding and management of mycological diseases. The journal's commitment to advancing knowledge is reflected in its Scopus rank of #120 out of 344 in Medicine - Infectious Diseases, positioning it within the 65th percentile. With open access options available, it aims to ensure that critical research is accessible to a global audience, enhancing collaboration and knowledge sharing among researchers, healthcare professionals, and students alike.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Advancing knowledge in microbiology and immunology.
Publisher: ELSEVIER TAIWANISSN: 1684-1182Frequency: 6 issues/year

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

REVISTA IBEROAMERICANA DE MICOLOGIA

Pioneering Discoveries in Mycology and Infectious Diseases
Publisher: ASOCIACION ESPANOLA MICOLOGIA-AEMISSN: 1130-1406Frequency: 4 issues/year

REVISTA IBEROAMERICANA DE MICOLOGIA, published by the ASOCIACION ESPANOLA MICOLOGIA-AEM, is a vital resource for those engaged in the study of mycology and infectious diseases. With a history spanning from 1996 to 2024, this journal is committed to advancing knowledge in the field through the dissemination of high-quality research articles, reviews, and case studies. Although it currently features a Q3 ranking in Infectious Diseases and a Q4 ranking in Microbiology for 2023, its impact is significant given the niche focus it serves, catering to a specialized audience of researchers and practitioners. While access is not open, the journal continues to be a preferred platform for scholarly communication among professionals in Spain and beyond. The editorial office, located in Bilbao, serves as the hub for rigorous peer-review and publication processes, ensuring that the latest advancements and findings in the field of mycology are effectively shared within the scientific community.

Medical Mycology Journal

Transforming Insights into Effective Treatments for Fungal Infections
Publisher: JAPANESE SOC MEDICAL MYCOLOGYISSN: 2185-6486Frequency: 4 issues/year

Medical Mycology Journal is a leading publication in the field of medical mycology, dedicated to advancing the understanding and treatment of fungal infections. Published by the Japanese Society of Medical Mycology, this journal serves as an essential resource for researchers, clinicians, and students alike. With an ISSN of 2185-6486 and an E-ISSN of 2186-165X, it aims to provide high-quality peer-reviewed articles focusing on clinical and epidemiological studies, diagnosis, and novel therapeutic approaches related to fungal pathogens. Operating under a Q3 ranking in Infectious Diseases and having consistently published significant findings since its establishment in 2011, the journal is pivotal for those working at the intersection of mycology and infectious disease management. Although currently non-open access, the journal's insights are vital for expanding knowledge in this critical area of healthcare, addressing pressing global health challenges linked to fungal infections.

SYDOWIA

Elevating Scientific Discourse in Ecology and Plant Studies
Publisher: VERLAG FERDINAND BERGER SOHNE GESELLSCHAFT MBHISSN: 0082-0598Frequency: 1 issue/year

SYDOWIA is a prestigious academic journal based in Austria, published by Verlag Ferdinand Berger Sohne Gesellschaft mbH, that has been a cornerstone of scientific publishing since its establishment in 1996. With an ISSN of 0082-0598, SYDOWIA focuses on critical research in the fields of Ecology, Evolution, Behavior and Systematics as well as Plant Science, earning a notable classification in Category Quartiles with Q3 in Ecology-related disciplines and Q2 in Plant Science for 2023. The journal’s strategic insights into agricultural and biological sciences have secured a place within the Scopus rankings, where it holds the position of #191 out of 516 in Plant Science and #278 out of 721 in Ecology categories—reflecting its growing influence with a percentile standing of 63rd and 61st, respectively. Although SYDOWIA is not an Open Access journal, it continues to thrive in delivering scholarly articles that promote advancement and innovation in ecological and botanical research. Researchers, professionals, and students alike can rely on SYDOWIA as a vital resource for disseminating knowledge and fostering exploration in these essential scientific domains.

JOURNAL DE MYCOLOGIE MEDICALE

Bridging Mycology and Clinical Practice
Publisher: MASSON EDITEURISSN: 1156-5233Frequency: 4 issues/year

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

mSphere

Empowering breakthroughs in the world of microorganisms.
Publisher: AMER SOC MICROBIOLOGYISSN: Frequency: 6 issues/year

mSphere is a leading open-access journal published by the American Society for Microbiology, dedicated to the dynamic fields of Microbiology and Molecular Biology. Since its inception in 2016, mSphere has rapidly established itself as a reputable source of scholarly research, achieving notable impact factors and excellence within the academic community. The journal ranks in the top quartile (Q1) amongst its peers in Microbiology, and Q2 in the field of Molecular Biology, demonstrating its significance and relevance through Scopus rankings—specifically, it holds the #42 spot out of 182 in the Microbiology category and #108 out of 410 in Molecular Biology. With an editorial commitment to advancing the understanding of microbial and molecular sciences, mSphere provides an accessible platform for researchers, professionals, and students alike to disseminate groundbreaking findings. The journal promotes rigorous peer-review and invites innovative contributions aimed at enhancing microbial research mobility and molecular exploration. Accessible openly since 2016, mSphere continues to thrive as an influential publication driving scientific dialogue and discovery in the microbiological sciences.

MycoKeys

Innovating mycology: bridging science and sustainability.
Publisher: PENSOFT PUBLISHERSISSN: 1314-4057Frequency: 2 issues/year

MycoKeys, published by PENSOFT PUBLISHERS, is a leading open-access journal dedicated to advancing the understanding of fungal biology and its diverse implications within agricultural, ecological, and biological sciences. With its ISSN 1314-4057 and E-ISSN 1314-4049, this journal has achieved remarkable academic prestige, reflected in its 2023 Scopus rankings placing it in the first quartile (Q1) across several categories, including Agricultural and Biological Sciences (miscellaneous), Ecology, Evolution, Behavior and Systematics, and Plant Science. MycoKeys provides a platform for researchers, professionals, and students interested in the latest findings and methodologies regarding fungi, their environments, and their interactions within various ecosystems. Since its transition to open access in 2011, the journal has championed the dissemination of high-quality research to a global audience, fostering collaboration and innovation in mycology. With a publishing history that converges from 2015 to 2024, MycoKeys remains a vital resource for those committed to exploring the multifaceted roles fungi play in our world.

IMA Fungus

Fostering Innovation in Ecological Research.
Publisher: BMCISSN: 2210-6340Frequency: 1 issue/year

IMA Fungus is an esteemed open-access journal published by BMC, dedicated to advancing research in the fields of fungi, plant sciences, and ecological systems. With an ISSN of 2210-6340 and E-ISSN 2210-6359, this journal has been an influential platform since its inception in 2010, contributing significantly to the scientific community in the United States and beyond. The journal’s remarkable impact can be seen in its Q1 quartile rankings across multiple categories, including Agricultural and Biological Sciences, Ecology, Evolution, Behavior and Systematics, and Plant Science, positioning it among the top literary sources in these fields. Notably, IMA Fungus holds impressive Scopus rankings, with the Agricultural and Biological Sciences category placing it in the 98th percentile, evidencing its crucial role in disseminating impactful research. Given its commitment to fostering accessibility and collaboration, IMA Fungus continues to be an invaluable resource for researchers, professionals, and students aiming to explore and understand the complex roles of fungi within various ecosystems.